相关实验视频
Updated: May 28, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
366
增加的神经素-1表达调节瘤恶性和食道状细胞癌的自性
Yen-Chiang Tseng1, Pei-Feng Liu2, Yu-Ru Chen3
1Division of Thoracic Surgery, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 81341, Taiwan, R.O.C.
International journal of molecular medicine
|February 14, 2025
概括
神经调节素-1 (NRG1) 在食道状细胞癌 (ESCC) 中高度表达,与预后不佳相关. 准NRG1,可能与自抑制剂,显示承诺作为ESCC的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 食道状细胞癌 (ESCC) 的5年生存率很低 (<20%),需要新的治疗点.
- 在ESCC中Neuregulin-1 (NRG1) 的作用和临床意义尚不清楚.
- NRG1是一种涉及细胞增殖和生存信号的跨膜蛋白.
研究的目的:
- 调查NRG1表达和ESCC之间的关联.
- 探索ESCC中准NRG1的治疗潜力.
主要方法:
- 对患者数据和癌症基因组图谱数据库的分析.
- 反转录定量PCR和NRG1表达的免疫组织化学.
- 试验室内实验涉及NRG1沉默和自抑制 ().
主要成果:
- 与正常组织相比,ESCC组织中的NRG1基因和蛋白质水平显著升高.
- 高NRG1表达与先进的ESCC和患者的不良结果相关.
- 沉默NRG1抑制了增殖,迁移和瘤球体的形成,同时通过破坏AKT和cRAF信号来增加细胞死亡.
- 抑制NRG1会诱导自,而自作为一种生存机制;抑制自会增强细胞死亡.
- NRG1和LC3B的同时表达与更糟糕的预后有关.
结论:
- NRG1是ESCC中潜在的预后生物标志物和治疗点.
- 针对NRG1,结合自抑制剂,代表了ESCC的有前途的治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K

